FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel derivatives of benzothiazolone of the general formula (I) β2- where X means or -SO2NH-; p, q and r = 2 or 3 being independently each of other; Y means thienyl optionally substituted with -NHSO2--alkyl or halogen atom or phenylthio-group or phenyl optionally substituted with C1-6-alkyl or halogen atom; each of R means independently H or C1-6-alkyl, its optical isomers and pharmaceutically acceptable salts. Method of synthesis of compound of the formula (I) or its pharmaceutically acceptable salt involves selective reductive alkylation of compound of the formula (II) C1-6 with compound of the formula (III) in the presence of reducing agent or by selective reduction of compound of the formula (IV) . Amide of the formula (VI) , acid of the formula (V) and aldehyde of the formula (III) are used as intermediate compounds for synthesis of benzothiazolone of the formula (I). Invention relates to also a pharmaceutical composition eliciting agonistic effect with respect to DA2-receptors and β2-adrenoreceptors and containing compound of the formula (I) or its pharmaceutically acceptable salt dispersed in propellant optionally containing vehicle, lubricating agents or stabilizing agents or as dry powder for inhalation optionally including pharmaceutically acceptable carrier. EFFECT: new derivatives of benzothiazolone indicated above, improved methods of synthesis, valuable pharmacological properties. 18 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 7-(2-AMINOETHYL)-BENZOTHIAZOLONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, DERIVATIVES OF N-[2-(4-HYDROXY-2-OXO-3H-1,3-BENZOTHIAZOLE-7-YL]-ETHYLAMIDE, PHARMACEUTICAL COMPOSITION SHOWING AGONISTIC ACTIVITY RELATIVE TO β-ADRENORECEPTORS | 1993 |
|
RU2114108C1 |
BENZOTHIAZOLONE ETHANEAMINES WITH BIOLOGICAL ACTIVITY | 1996 |
|
RU2177476C2 |
DERIVATIVES OF 3-H-1,2,3-TRIAZOLO-[4,5-D]-PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2174518C2 |
DERIVATIVES OF N-HETEROARYLPYRIDINESULFONEAMIDE, METHODS OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF COUNTERACTION TO ONE OR MORE EFFECTS OF ENDOTHELIN | 1996 |
|
RU2172738C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2005 |
|
RU2389731C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
Authors
Dates
2001-08-20—Published
1996-09-12—Filed